सर्वश्रेष्ठ Cite पॉडकास्टस (2024)

1
#72 - Lili Sohn - Autrice et dessinatrice de BD ! 29:27

24h ago29:27

29:27

Alors ?! Vous en pensez quoi de cette nouvelle identité sonore ?! J’espère qu’elle vous plait autant qu’à moi car après avoir posté 70 épisodes j’avais envie de changement, de renouvellement même si évidemment sur le fond rien ne bouge : Marseille reste le fil rouge de mes rencontres ! Marseille bouillonnante, arlequinée, agitée ;)) Et c’est un bon…

1
Ep 87 May 2024 Fourth Circuit Update 31:23

21d ago31:23

31:23

Jonathan Byrne and Josh Carpenter of the Western District of North Carolina Federal Public Defender Office discuss recent Fourth Circuit news.

1
China Biotech Podcast - 5 June 2024 (Chinese language) 23:09

1d ago23:09

23:09

Guest speaker Guangzuo Luo, chief scientific officer of Bioncetech, joins China-based editors Brian Yang and Dexter Yan in this episode, which looks at Chinese biotechs going global, and the opportunities and challenges in the latest industry latest trends.https://scrip.citeline.com/SC150370/China-Biotech-Podcast-Going-Global-Trends-Rare-Disease-Dr…

1
JB CEO On CDMO Growth, Red Sea Crisis And More 34:06

2d ago34:06

34:06

In an interview with Scrip, JB CEO Nikhil Chopra addresses rumours of a sale of a stake in the Indian pharma/CDMO company by private equity fund KKR, recent acquisitions, including from Novartis, as well as JB's ambitions to ramp up the cardiology segment and its CDMO business, which already has major clients including J&J and P&G.https://scrip.cit…

1
Scrip's Five Must-Know Things - 3 June 2024 15:09

3d ago15:09

15:09

Audio roundup of selected biopharma industry content from Scrip over the business week ended 31 May 2024. In this episode: ASCO preview; Asahi’s US acquisition; Novartis aims for renal disease dominance; paying for gene therapies; and US BIOSECURE Act diluted.https://scrip.citeline.com/SC150361/Quick-Listen-Scrips-Five-MustKnow-ThingsPlaylist: http…

1
The Scrip Awards Podcast. Episode 1: Genmab: The Ongoing Evolution Of Europe’s Antibody Powerhouse 22:15

6d ago22:15

22:15

An interview with Genmab’s Jan van de Winkel to mark 25 years of the company, and 20 years of the Scrip Awards. A brief history of the antibody-focused biotech company so far, and its plans for future expansion.द्वारा Citeline

1
How Corporate Sustainability Reporting ‘Just Got Serious,’ With CEN-ESG’s Jasper Crone 50:18

6d ago50:18

50:18

In this episode we unpack the Corporate Sustainability Reporting Directive (CSRD) with the help of ESG expert Jasper Crone, drilling down into exactly what consumer healthcare companies need to know about this enormously complex and significant piece of EU legislation.3:30 Introduction to the CSRD7:45 What companies are affected by the CSRD15:00 Sp…

1
Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions 37:01

6d ago37:01

37:01

Advancing Investigational New Drugs (INDs) can be a complex process, especially for smaller companies. Listen to your free podcast now as Marcus Delatte, PhD, Vice President at Allucent and Harshini Neelakantan, Executive Director at Ridgeline Therapeutics discuss best practices and considerations for leveraging your pre-IND meeting and submitting …

1
'CorpPharma Is Not Just A Cost Component’ – Showcasing Value As Well As Innovation 35:52

8d ago35:52

35:52

Astellas Pharma’s chief commercial officer, Claus Zieler, discusses the biopharma industry’s responsibility to drive change in health care.द्वारा Citeline

1
China Biotech CEO Interview - NeuShen's Joan Huaqiong Shen 45:35

9d ago45:35

45:35

NeuShen CEO Joan Shen discusses with Brian Yang about developing CNS drugs in China, the venture's business rationale, challenges and fundraising. She also discusses two leading assets for schizophrenia and epilepsy in first-in-human studies, as well as a gene therapy collaboration for ALS with UMass's Gao Lab.https://scrip.citeline.com/SC150328/Ch…

1
Citeline Japan Awards 2024 - Enter Now! (Bilingual English/Japanese) 5:16

9d ago5:16

5:16

As the 15 July entry deadline for the 3rd edition of the annual Citeline Japan Awards approaches, join us in this bilingual English/Japanese podcast to learn more about the categories and event itself. (Japanese starts at 2' 25".)English event site: https://www.citeline.com/en/awards/citelinejapanawardsJapanese event site: https://www.citeline.com/…

1
Scrip's Five Must-Know Things - 27 May 2024 16:00

10d ago16:00

16:00

Audio roundup of selected biopharma industry content from Scrip over the business week ended 24 May 2024. In this episode: Biogen’s immunology acquisition; AstraZeneca looks to cement respiratory lead; why US FTC is tough on pharma; the US election’s impact on pharma; and how new AI tools are impacting medical affairs.https://scrip.citeline.com/SC1…

1
Drug Fix: Novel Clinical Trial Reg Problems, NIH Drug ‘Access Plans’, Good Ole Days Of Woodcock 23:09

12d ago23:09

23:09

Pink Sheet editors discuss the US FDA’s consideration of regulatory changes to promote innovative clinical trial designs (:32), an NIH proposal to require patent licensees create plans to ensure access to the commercialized product (7:29), and lawmakers longing for the days when Janet Woodcock ran the FDA’s Center for Drug Evaluation and Research (…

1
【3分で解説世界のファーマ】第18回 GLP-1を超える肥満治療薬のカギとは？(Japanese-language podcast) 3:31

14d ago3:31

3:31

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら「Hibernating Squirrels And Exercise In A Pill: The Next Wave of Cardiometabolic Therapies（邦題意訳：GLP-1を超える心代謝系治療薬のヒントは、冬眠するリスか、地道な運動か）」（日本語版）https://www.citeline.com/ja-jp/resources/hibernating-squirrels-and-exercise-in-a-pill※全文の閲覧には情…

1
Closed Loop Medicine: Pairing Software With Drugs To Optimize Dosing 25:21

15d ago25:21

25:21

In this episode of the In Vivo podcast, Hakim Yadi, CEO and co-founder of UK techbio company Closed Loop Medicine, discusses how his company is pairing software and predictive analytics with medications old and new to tailor drug dosing to each patient.द्वारा Citeline

1
Leading PRO Discusses Plans For Administering State EPR Programs 36:59

15d ago36:59

36:59

In this episode, HBW chats with John Hite of the leading producer responsibility organization administering three Extended Producer Responsibility laws launching next year. With a 1 July deadline to register for his PRO, Circular Action Alliance, Hite discusses steps companies should take now, how his organization will assist producers and expectat…

1
개발 VS 딜메이킹: 블록버스터 신약을 확보하는 방법 (Korean-language podcast) 3:24

16d ago3:24

3:24

빅파마 기업들의 블록버스터 신약 확보 전략에 대한 Scrip 기사를 요약한 내용입니다.https://scrip.citeline.com/SC150256/Development-Versus-Dealmaking-How-To-Obtain-A-BlockbusterPlaylist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-miniद्वारा Citeline

1
How To Grow A Consumer Health Brand, With TheOTCLab’s Albert Swane 32:07

17d ago32:07

32:07

In this episode, HBW Insight catches up with Albert Swane, founder and CEO of Dutch consumer healthcare firm, TheOTCLab, to talk about business strategy. Having grown the company with widely successful European OTC medical devices like Dr. Yglo, FungeX and Kidsner, Swane is perfectly placed to explain how to create and grow OTC brands. Swane also o…

1
Scrip's Five Must-Know Things - 20 May 2024 16:55

17d ago16:55

16:55

Audio roundup of selected biopharma industry content from Scrip over the business week ended 17 May 2024. In this episode: the life of a blockbuster; blockbusters by indication; gene therapy struggles; sun shines on AstraZeneca and GSK; and Korean ventures look to Japan.https://scrip.citeline.com/SC150281/Quick-Listen-Scrips-Five-MustKnow-ThingsPla…

1
Drug Fix: BIOSECURE Act Advances, Trial Diversity Sticks, Platform Principles Without Designation 38:55

19d ago38:55

38:55

Pink Sheet editors and reporter consider the implications of the BIOSECURE Act as it advances through a House committee (:30), whether industry would improve clinical trial diversity with tougher enforcement of the regulation (22:26), as some have suggested, and the FDA’s use of platform technology ideas for gene therapies not participating in the …

1
May 2024 Datamonitor Healthcare Podcast: Neoadjuvant Therapy in Melanoma 16:04

20d ago16:04

16:04

Flora gives an overview of the budding landscape of neoadjuvant therapy in melanoma and provides insight on the nuances of this market.Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZX…

1
Ep 86 April 2024 Fourth Circuit and Supreme Court Update 33:25

21d ago33:25

33:25

Jonathan Byrne and Alicia Penn of the District of South Carolina Federal Public Defender Office discuss recent Fourth Circuit and Supreme Court news.

1
China Biotech Podcast - 15 May 2024 (Chinese- and English-Language) 35:28

22d ago35:28

35:28

In this bilingual Chinese- and English-language edition, China-based editors Brian Yang and Dexter Yan, along with guest speaker Derrick Gingery from the Pink Sheet in the US, discuss the planned US BIOSECURE Act and markup vote. Brian and Dexter also look at recent R&D updates from Chinese biopharma firms on their antibody-drug conjugate pipelines…

1
Scrip's Five Must-Know Things - 13 May 2024 14:29

24d ago14:29

14:29

Audio roundup of selected biopharma industry content from Scrip over the business week ended 10 May 2024. In this episode: AstraZeneca’s Vaxzevria farewell; the next wave of cardiometabolics; Pfizer recruits prominent analyst: foundation pleas for China rare disease therapies; and Gossamer partners up for respiratory therapy.https://scrip.citeline.…

1
Episode 15: Digital Trust 20:20

27d ago20:20

20:20

In this episode, Medtech Insight senior reporter Hannah Daniel speaks to Mark Brown, Global Managing Director of Digital Trust Consulting at the British Standards Institute about digital trust. In a world of cybersecurity breaches and ransomware attacks on hospitals, digital trust between companies and consumers is key, but current siloed operation…

1
Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta 29:28

29d ago29:28

29:28

In this episode, HBW Insight chats with sustainable packaging expert Tony Perrotta about why it’s so difficult to replace plastic pill packs in medicines packaging. Perrotta works for PA Consulting, which set up the Blister Pack Collective alongside consumer healthcare partners Haleon, Bayer and Sanofi. They are working with PulPac, which has inven…

1
Scrip's Five Must-Know Things - 7 May 2024 15:01

1M ago15:01

15:01

Audio roundup of selected biopharma industry content from Scrip over the business week ended 3 May 2024. In this episode: Japan’s Ono buys US oncology firm; strong growth but supply issues for Lilly; Novo and Lilly make their money work; BMS cuts jobs, costs; and Big Pharma’s support for bioventures.https://scrip.citeline.com/SC150211/Quick-Listen-…

1
Drug Fix: US FDA Adcomm Reform, A Boost For Clinical Trial Modeling, AI For Drug Review 31:23

1M ago31:23

31:23

Pink Sheet reporter and editors discuss what an upcoming listening session means for the FDA’s advisory committee reform effort (:32), the agency’s efforts to help the clinical trial modeling and simulation industry (16:22), and the UK’s MHRA plan to use artificial intelligence to assist in drug application reviews (21:05).More On These Topics From…

1
Digital Health Roundup: US FDA’s ‘Idea Lab’; Philips’ Roy Jakobs On AI Draft Framework; Apple Watch 6:35

1M ago6:35

6:35

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights key interviews with Philips’ CEO Roy Jakobs on NAM’s draft framework on AI, BD’s CTO Beth McCombs R&D initiatives and HSS spine co-chair Sheeraz Qureshi on his vision for integrating AI tech. Hannah Daniel discusses the FDA’s new initiative to create an idea lab for me…

1
April Datamonitor Podcast 2024: AAN coverage 51:54

1M ago51:54

51:54

Flora and Emma are joined by Datamonitor’s CNS analysts Summer, Joseph, and Wen-Yu to discuss coverage from AAN.Other platforms (in addition to SoundCloud):Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vy…

1
28.04.2024 - Jean 15:18-Jean 16:7 - Un Autre Monde(Frederic Dalais) 42:33

1M ago42:33

42:33

28.04.2024 - Jean 15:18-Jean 16:7 - Un Autre Monde(Frederic Dalais) by La Citéद्वारा La Cité

1
21.04.2024 - Jean 15:1-17 - Jesus The True Vine (Simona Vilcu) 47:17

1M ago47:17

47:17

21.04.2024 - Jean 15:1-17 - Jesus The True Vine (Simona Vilcu) by La Citéद्वारा La Cité

1
14.04.2024 - Jean 14:14-31 - Promesse de Jésus d’Envoyer Un Autre Défenseur (Frederic Dalais) 29:07

1M ago29:07

29:07

14.04.2024 - Jean 14:14-31 - Promesse de Jésus d’Envoyer Un Autre Défenseur (Frederic Dalais) by La Citéद्वारा La Cité

1
07.04.2024 - Jean 14:1-14 (Frederic Dalais) 38:20

1M ago38:20

38:20

07.04.2024 - Jean 14:1-14 (Frederic Dalais) by La Citéद्वारा La Cité

1
31.03.2024 - Message de Pacques (Nathan de l'église Fireplace) 44:12

1M ago44:12

44:12

31.03.2024 - Message de Pacques (Nathan de l'église Fireplace) by La Citéद्वारा La Cité

1
Scrip's Five Must-Know Things - 30 April 2024 14:15

1M ago14:15

14:15

Audio roundup of selected biopharma industry content from Scrip over the business week ended 26 April 2024. In this episode: 2023’s top selling drugs and the COVID cliff; falling sales force Roche to reassess priorities; Phase III immunology win for Sanofi; BMS’s strong pipeline: and which companies could be acquired next.https://scrip.citeline.com…

1
2024 Global Generics & Biosimilars Awards 4:30

1M ago4:30

4:30

2024 Global Generics & Biosimilars Awards by Citelineद्वारा Citeline

1
Podcast: Facilitating Patient Monitoring in CAR-T Development 19:28

1M ago19:28

19:28

Learn how molecular technology is enhancing patient safety for CAR-T clinical trials. US FDA recently initiated class safety labeling changes after evaluating the safety of CAR-T cancer treatment therapies. What does this mean for developers in the CAR-T landscape? Listen to your free podcast to find out.Listen in on the conversation as experts fro…

1
Drug Fix: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics 34:14

1M ago34:14

34:14

Pink Sheet reporter and editors discuss the impact of FDA biosimilar promotion guidance on the future of the interchangeability designation (:34), upcoming guidance on accelerated approval for gene therapies (14:15), and partisan attacks on the agency from Capitol Hill (27:13).More On These Topics From The Pink SheetRx Advertising: Interchangeabili…

1
Dr. Xue Discusses Treatment Guideline Updates for COPD in This Q&A Session 10:15

1M ago10:15

10:15

Pulmonologist Bing Xue, MD, reviews the latest GOLD guidelines and discusses relevant topics regarding COPD treatment.द्वारा Citeline

1
China Biotech Podcast - 26 April 2024 (Chinese and English Language) 28:19

1M ago28:19

28:19

Join Scrip's China-based editors Brian Yang and Dexter Yan in this Chinese/English podcast as they look at data presented to AACR by Chinese pharma firms and recent acquisitions of China-based companies. UK-based writer Andrew McConaghie also joins to provide his perspectives, including on the proposed US BIOSECURE Act.https://scrip.citeline.com/SC…

1
Future Governance & Oversight of the EU Medtech Regulatory System 55:58

1M ago55:58

55:58

Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.द्वारा Citeline

1
Citeline - Cerba Research Podcast V2 19:28

1M ago19:28

19:28

Citeline - Cerba Research Podcast V2 by Citelineद्वारा Citeline

1
Scrip M&A Podcast: Are Buyers Coming For Viking, Verona, Altimmune, Xenon And Crinetics 45:57

1M ago45:57

45:57

Scrip's Joseph Haas, Kevin Grogan and Edwin Elmhirst talk about the biopharma M&A environment and which companies might look particularly appealing to potential acquirers.द्वारा Citeline

1
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections 18:38

1M ago18:38

18:38

In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.द्वारा Citeline

1
Over The Counter 22 April 2024 22:13

1M ago22:13

22:13

Helping Consumers ‘Tune In’ To Reliable Health Information, With Kaizo’s Anita Nahal“Consumers are rewriting the rules when it comes to where they are going for information and the type of information they are looking for,” reports Kaizo’s Anita Nahal, speaking to HBW Insight’s Over the Counter podcast about the agency’s latest Communicating Health…

1
Scrip's Five Must-Know Things - 22 April 2024 14:54

2M ago14:54

14:54

Audio roundup of selected biopharma industry content from Scrip over the business week ended 19 April 2024. In this episode: Teva’s immunology biosimilar launches; Intra-Cellular’s promising depression data; Phase III sleep apnea win for Lilly’s tirzepatide; an interview with Viking’s CEO; and China looks to define innovative drugs.https://scrip.ci…

1
Drug Fix: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development 30:58

2M ago30:58

30:58

Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi (:28), Janet Woodcock’s new post-FDA role (12:28), and ongoing preparations for new pneumococcal vaccines that will reach the market soon (17:28).#business #pharmaMore On These Topics From The Pink SheetMedicare Spending Forecast For Leqembi Reflects CMS …

1
Next-Generation Diagnostics: "Breathomics" From Imspex 14:29

2M ago14:29

14:29

A new diagnostic technology to screen and triage individuals based on breath.द्वारा Citeline

1
Ratio Therapeutics On BMS Buy-In, Radiopharma R&D Trends, AI And Assets 39:09

2M ago39:09

39:09

Scrip’s senior editor Vibha Ravi speaks with Jack Hoppin, CEO and chairman, and John Babich, chief scientific officer, at Ratio Therapeutics, about the company’s radiopharmaceuticals pipeline, investment by BMS, use of AI, trends and developments in radiopharma research like combining ADCs or PARP inhibitors and more.https://scrip.citeline.com/SC15…

पॉडकास्ट सुनने लायक

Cite पॉडकास्टस

पॉडकास्ट सुनने लायक

त्वरित संदर्भ मार्गदर्शिका